Disparities in the Diagnosis and Pharmacologic Treatment of High Serum Cholesterol by Race and Ethnicity

Abstract
RECENT DECLINES in death rates from coronary heart disease (CHD) have been more significant in whites than in minority populations in the United States.1-3 Many studies4-8 have shown that Latinos and African Americans receive less aggressive treatment for CHD than do whites. However, there are conflicting data on racial and ethnic variation in the primary prevention of CHD. Elevated serum cholesterol is one of the most important modifiable risk factors for CHD,9-11 and treating hypercholesterolemia lowers the risk of developing disease.12-16 Given the strength of this evidence, the National Cholesterol Education Program recommends measuring the serum cholesterol in all adults older than 20 years at least once every 5 years.9

This publication has 39 references indexed in Scilit: